KATHMANDU (Reuters) – Nepal on Friday granted approval for AstraZeneca’s COVISHIELD vaccine against the novel coronavirus in the country.
“Conditional permission has been granted for emergency use authorization of COVISHIELD vaccine against COVID-19 in Nepal,” a statement by the country’s Department of Drug Administration said.
Nepal has reported 266,816 cases and 1,948 deaths from COVID-19 so far, according to official data.
(Reporting by Gopal Sharma; Writing by Alasdair Pal; Editing by Jan Harvey)
